Literature DB >> 27619672

D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization.

Nicolas H Pope1, Morgan Salmon1, John P Davis1, Anuran Chatterjee2, Gang Su1, Michael S Conte2, Gorav Ailawadi1, Gilbert R Upchurch3.   

Abstract

The role of resolvins in abdominal aortic aneurysm (AAA) has not been established. We hypothesized that treatment with D-series resolvins (RvD2 or RvD1) would attenuate murine AAA formation through alterations in macrophage polarization and cytokine expression. Male C57/B6 mice (n = 9 per group) 8 to 12 wk old received RvD2 (100 ng/kg/treatment), RvD1 (100 ng/kg/treatment), or vehicle only every third day beginning 3 d before abdominal aortic perfusion with elastase as prevention. Aortas were collected 14 d after elastase perfusion. Cytokine analysis (n = 5 per group) or confocal microscopy (n = 4 per group) was performed. In a separate experiment, RvD2 was provided to mice with small AAAs 3 d after elastase treatment (n = 8 per group). Additionally, apolipoprotein E knockout mice treated with angiotensin II (1000 ng/kg) were treated with RvD2 or vehicle alone (n = 10 per group) in a nonsurgical model of AAA. To determine the effect of RvD2 on macrophage polarization, confocal staining for macrophages, M1 and M2 macrophage subtypes, α-actin, and DAPI was performed. Mean aortic dilation was 96 ± 13% for vehicle-treated mice, 57 ± 9.7% for RvD2-treated mice, and 61 ± 11% for RvD1-treated mice (P < 0.0001). Proinflammatory cytokines macrophage chemotactic protein 1, C-X-C motif ligand 1, and IL-1β were significantly elevated in control animals compared to RvD2- and RvD1-treated animals (P < 0.05), resulting in a reduction of matrix metalloproteinase 2 and 9 activity in resolvin-treated mice in both elastase and angiotensin II models. Treatment of existing small AAAs with RvD2 demonstrated a 25% reduction in aneurysm size at d 14 compared to vehicle alone (P = 0.018). Confocal histology demonstrated a prevalence of M2 macrophages within the aortic medium in mice treated with RvD2. Resolvin D2 exhibits a potent protective effect against experimental AAA formation. Treatment with RvD2 significantly influences macrophage polarization and decreases several important proinflammatory cytokines. Resolvins and the alteration of macrophage polarization represent potential future targets for prevention of AAA.-Pope, N. H., Salmon, M., Davis, J. P., Chatterjee, A., Su, G., Conte, M. S., Ailawadi, G., Upchurch, G. R., Jr. D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization. © FASEB.

Entities:  

Keywords:  inflammation; proresolving mediators; vascular biology

Mesh:

Substances:

Year:  2016        PMID: 27619672      PMCID: PMC5102115          DOI: 10.1096/fj.201600144RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  45 in total

Review 1.  Macrophage polarization comes of age.

Authors:  Alberto Mantovani; Antonio Sica; Massimo Locati
Journal:  Immunity       Date:  2005-10       Impact factor: 31.745

Review 2.  Current concepts in the pathogenesis of abdominal aortic aneurysm.

Authors:  Gorav Ailawadi; Jonathan L Eliason; Gilbert R Upchurch
Journal:  J Vasc Surg       Date:  2003-09       Impact factor: 4.268

3.  Omega 3 Polyunsaturated Fatty Acids Suppress the Development of Aortic Aneurysms Through the Inhibition of Macrophage-Mediated Inflammation.

Authors:  Takuma Yoshihara; Kazunori Shimada; Kosuke Fukao; Eiryu Sai; Yayoi Sato-Okabayashi; Rie Matsumori; Tomoyuki Shiozawa; Hamad Alshahi; Tetsuro Miyazaki; Norihiro Tada; Hiroyuki Daida
Journal:  Circ J       Date:  2015-04-30       Impact factor: 2.993

4.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

Authors:  A Daugherty; M W Manning; L A Cassis
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

5.  Randomized clinical trial of screening for abdominal aortic aneurysm in women.

Authors:  R A P Scott; S G Bridgewater; H A Ashton
Journal:  Br J Surg       Date:  2002-03       Impact factor: 6.939

6.  Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice.

Authors:  Daisuke Akagi; Mian Chen; Robert Toy; Anuran Chatterjee; Michael S Conte
Journal:  FASEB J       Date:  2015-03-16       Impact factor: 5.191

7.  Dietary supplementation with omega-3 polyunsaturated fatty acids modulate matrix metalloproteinase immunoreactivity in a mouse model of pre-abdominal aortic aneurysm.

Authors:  Kristyn Kavazos; Maria Nataatmadja; Kathryn M Wales; Elke Hartland; Chloe Williams; Fraser D Russell
Journal:  Heart Lung Circ       Date:  2014-11-20       Impact factor: 2.975

8.  Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation.

Authors:  William F Johnston; Morgan Salmon; Gang Su; Guanyi Lu; Matthew L Stone; Yunge Zhao; Gary K Owens; Gilbert R Upchurch; Gorav Ailawadi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

Review 9.  Inflammation and cellular immune responses in abdominal aortic aneurysms.

Authors:  Koichi Shimizu; Richard N Mitchell; Peter Libby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-02-23       Impact factor: 8.311

10.  Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm.

Authors:  Paul E Norman; Konrad Jamrozik; Michael M Lawrence-Brown; Max T Q Le; Carole A Spencer; Raywin J Tuohy; Richard W Parsons; James A Dickinson
Journal:  BMJ       Date:  2004-11-15
View more
  40 in total

Review 1.  Monocytes and macrophages in abdominal aortic aneurysm.

Authors:  Juliette Raffort; Fabien Lareyre; Marc Clément; Réda Hassen-Khodja; Giulia Chinetti; Ziad Mallat
Journal:  Nat Rev Cardiol       Date:  2017-04-13       Impact factor: 32.419

Review 2.  Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology.

Authors:  Charles N Serhan
Journal:  Mol Aspects Med       Date:  2017-03-03

3.  n-3 PUFAs improve erythrocyte fatty acid profile in patients with small AAA: a randomized controlled trial.

Authors:  Lara T Meital; Mark T Windsor; Rebecca M L Ramirez Jewell; Peter Young; Karl Schulze; Rebecca Magee; Jill O'Donnell; Pankaj Jha; Maria Perissiou; Jonathan Golledge; Tom G Bailey; Peter Brooks; Christopher D Askew; Fraser D Russell
Journal:  J Lipid Res       Date:  2019-03-26       Impact factor: 5.922

Review 4.  New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration.

Authors:  Charles N Serhan; Nan Chiang; Jesmond Dalli
Journal:  Mol Aspects Med       Date:  2017-09-01

Review 5.  Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections.

Authors:  Ying H Shen; Scott A LeMaire
Journal:  Curr Probl Surg       Date:  2017-02-03       Impact factor: 1.909

6.  Biosynthesis of proresolving lipid mediators by vascular cells and tissues.

Authors:  Anuran Chatterjee; Sevan Komshian; Brian E Sansbury; Bian Wu; Giorgio Mottola; Mian Chen; Matthew Spite; Michael S Conte
Journal:  FASEB J       Date:  2017-04-25       Impact factor: 5.191

7.  ZFP148 (Zinc-Finger Protein 148) Binds Cooperatively With NF-1 (Neurofibromin 1) to Inhibit Smooth Muscle Marker Gene Expression During Abdominal Aortic Aneurysm Formation.

Authors:  Morgan Salmon; Basil Schaheen; Michael Spinosa; William Montgomery; Nicolas H Pope; John P Davis; William F Johnston; Ashish K Sharma; Gary K Owens; Juanita L Merchant; Zendra E Zehner; Gilbert R Upchurch; Gorav Ailawadi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-01       Impact factor: 8.311

8.  Pharmacologic inhibition of transient receptor channel vanilloid 4 attenuates abdominal aortic aneurysm formation.

Authors:  Alexander H Shannon; Craig T Elder; Guanyi Lu; Gang Su; Alexis Mast; Morgan D Salmon; William G Montgomery; Michael D Spinosa; Gilbert R Upchurch; Ashish K Sharma
Journal:  FASEB J       Date:  2020-06-07       Impact factor: 5.191

Review 9.  Metabololipidomic profiling of functional immunoresolvent clusters and eicosanoids in mammalian tissues.

Authors:  Paul C Norris; Charles N Serhan
Journal:  Biochem Biophys Res Commun       Date:  2018-03-15       Impact factor: 3.575

Review 10.  Can Specialized Pro-resolving Mediators Deliver Benefit Originally Expected from Fish Oil?

Authors:  Martin D Rosenthal; Jayshil Patel; Kyle Staton; Robert G Martindale; Frederick A Moore; Gilbert R Upchurch
Journal:  Curr Gastroenterol Rep       Date:  2018-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.